Sep 1, 2026 07:37AM
Aug 24, 2026 08:51AM
Aug 24, 2026 08:05AM
Aug 13, 2026 07:36AM
Aug 6, 2026 08:00AM
Jul 30, 2026 08:30AM
Jul 28, 2026 07:47AM Clearmind completes Part A of Phase I/II trial for alcohol disorder drug
Jul 20, 2026 07:55AM
Jul 17, 2026 07:32AM
Jul 16, 2026 09:30AM
Jul 13, 2026 08:17AM
Jul 10, 2026 08:32AM
Jul 7, 2026 07:43AM
Jun 22, 2026 08:07AM Clearmind completes Part A of FDA-regulated AUD drug trial
Jun 16, 2026 07:32AM
May 29, 2026 08:41AM
May 26, 2026 08:25AM
May 12, 2026 08:41AM
May 5, 2026 08:53AM
Apr 20, 2026 04:03PM
Apr 20, 2026 07:15AM Clearmind Medicine meets safety endpoint in alcohol disorder trial
Apr 14, 2026 07:32AM
Mar 30, 2026 08:32AM
Mar 17, 2026 09:15AM
Mar 13, 2026 07:46AM
Mar 11, 2026 09:08AM
Mar 10, 2026 08:59AM
Mar 4, 2026 07:30AM Clearmind Medicine advances to next phase of alcohol disorder trial
Feb 19, 2026 04:15PM
Feb 9, 2026 08:17AM
Feb 9, 2026 08:17AM
Feb 9, 2026 08:00AM
Feb 6, 2026 08:02AM
Feb 6, 2026 07:57AM
Jan 14, 2026 08:55AM Clearmind Medicine completes treatment for second patient cohort in trial
Dec 24, 2025 09:15AM
Dec 16, 2025 08:45AM
Dec 5, 2025 05:01PM
Dec 2, 2025 07:57AM
Dec 1, 2025 08:57AM
Nov 26, 2025 04:18PM
Nov 25, 2025 07:17AM Clearmind Medicine enrolls first patient at Tel Aviv medical center
Nov 24, 2025 08:51AM
Nov 20, 2025 06:45AM
Nov 20, 2025 06:01AM
Nov 18, 2025 08:57AM
Nov 17, 2025 07:55AM
Nov 10, 2025 08:07AM
Nov 5, 2025 06:55AM Clearmind files patent in South Korea for MEAI depression treatment
Oct 31, 2025 07:35AM

457,658 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All